| CTRI Number |
CTRI/2026/01/102126 [Registered on: 27/01/2026] Trial Registered Prospectively |
| Last Modified On: |
23/09/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Non-randomized, Multiple Arm Trial |
|
Public Title of Study
|
A comparative study of homoeopathic decimal and centesimal scales in treatment of hair falling in aged 20-50 years using the hair shedding visual scale and hair pull test |
|
Scientific Title of Study
|
A comparative study: effectiveness of homoeopathic decimal and centesimal scales in the management of telogen effluvium aged 20–50 years using the HSVS and hair pull test –a individualised approach |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Poojabahen Kanubhai Parmar |
| Designation |
PG Scholar |
| Affiliation |
Parul institute of homoeopathy and research hospital |
| Address |
Parul institute of homoeopathy and research hospital,3rd floor room no.401, Department of Homoeopathic Pharmacy, At. Ishwarpura po. Limda Ta. Waghodia di. Vadodara
Vadodara
GUJARAT
391760
India |
| Phone |
9484463452 |
| Fax |
|
| Email |
poojakparmar78@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Nayana Patel |
| Designation |
Associate Professor |
| Affiliation |
Parul institute of homoeopathy and research hospital |
| Address |
Parul institute of homoeopathy and research hospital,3rd floor room no.401, Department of Homoeopathic Pharmacy, At. Ishwarpura po. Limda Ta. Waghodia di. Vadodara
Vadodara
GUJARAT
391760
India |
| Phone |
8128815189 |
| Fax |
|
| Email |
nayanaben.patel17843@paruluniversity.ac.in |
|
Details of Contact Person
Public Query
|
| Name |
Poojabahen Kanubhai Parmar |
| Designation |
PG Scholar |
| Affiliation |
Parul institute of homoeopathy and research hospital |
| Address |
Parul institute of homoeopathy and research hospital,3rd floor room no.401, Department of Homoeopathic Pharmacy, At. Ishwarpura po. Limda Ta. Waghodia di. Vadodara
Vadodara
GUJARAT
391760
India |
| Phone |
9484463452 |
| Fax |
|
| Email |
poojakparmar78@gmail.com |
|
|
Source of Monetary or Material Support
|
| Parul Institute of Homoeopathy and Research Hospital |
|
|
Primary Sponsor
|
| Name |
Parul Institute of Homoeopathy and Research |
| Address |
Parul Institute of Homoeopathy and Research, At. Ishwarpura, Po. Limda, Ta. Waghodia, Di. Vadodara-391760 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Poojabahen Kanubhai Parmar |
Parul Institute of Homoeopathy and Research, At. Ishwarpura, Po. Limda, Ta. Waghodia, Di. Vadodara-391760 |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Poojabahen Kanubhai Parmar |
Parul Institute of Homoeopathy and Research Hospital |
Parul Institute of Homoeopathy and Research Hospital,3rd floor, room no,401, department of Homoeopathic Pharmacy AT. Ishwarpura, po. Limda, ta. Waghodia di. Vadodara
Vadodara
GUJARAT |
9484463452
poojakparmar78@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee For Human Research |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: L650||Telogen effluvium, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Individualised homoeopathic medicine |
The intervention in this study is Participants diagnosed with Telogen Effluvium and fulfilling the inclusion criteria will receive individualised homoeopathic treatment based on the totality of symptoms. Remedies will be selected according to homoeopathic principles and prescribed in either decimal or centesimal potency scales. Participants will be allocated into two groups based on the potency scale used. The prescribed medicines will be administered in appropriate dosage and repetition as per individual case requirement. Follow-up assessments will be conducted every 15 days to evaluate treatment response, adjust potency or medicine if required, and monitor outcomes using the Hair Shedding Visual Scale (HSVS) and Hair Pull Test. The medicine will be administered through the oral route. |
| Comparator Agent |
Not applicable |
Not applicable |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Both |
| Details |
Patients diagnosed with telogen effluvium, confirmed through clinical history and positive hair pull test.
Post-febrile illness (e.g., after dengue, typhoid, covid-19, influenza). postpartum state (within 12 months of delivery). Psychological stress, anemia, scalp infections or fungal diseases.
|
|
| ExclusionCriteria |
| Details |
Patients with other forms of alopecia (e.g., alopecia areata, androgenetic alopecia, scarring alopecia).
Pregnant or lactating women.
Patients with underlying systemic disorders like: autoimmune diseases (e.g., lupus), diabetes mellitus, pcod, thyroid disorder and also patients on chemotherapy or radiotherapy.
Patients currently using or having recently used topical steroids, minoxidil, or systemic treatments for hair loss.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the usefulness of decimal and centesimal scale in the management of telogen effluvium. |
3 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To assess improvement in hair fall using hair shedding visual scale. |
3 months |
|
|
Target Sample Size
|
Total Sample Size="30"
Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
02/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="0"
Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is a comparative clinical study design to evaluate the usefulness of Homoeopathic medicines prescribed in decimal and centesimal scale in the management of Telogen Effluvium in aged group 20-50 years. The study will be conducted at Parul Institute of Homoeopathy and Research Hospital, Vadodara, with a total sample size of 30 patients and a study duration of 3 months. Each patient will receive individualised homoeopathic treatment based on detailed case taking and totality of symptoms. the outcome of the study will be the assessment of improvement in hair shedding by using hair shedding visual scale and hair pull test before and after treatment and also in every follow ups. Patients will be divided into two groups, each receiving homoeopathic treatment in either decimal or centesimal potency scales. The results will be statistically analyzed to compare the efficacy of both scales. The study aims to provide scientific evidence regarding the most effective potency scale in the management of telogen effluvium. |